After-Hours Movers 5/4: AIMC, NATL, ATSI, HLF, TAST Higher; HLIT, HOLX, MYGN, GSX, ARRY Lower

May 4, 2009 5:54 PM EDT

Harmonic (Nasdaq: HLIT) 16.5% LOWER; reports Q1 EPS of $0.04, ex-items, 1 cent lower than the analyst estimate of $0.05. Revenue for the quarter was $678 million, versus the consensus of $75.17 million. Sees Q2 revs of $72-$78 million, versus the consensus of $80.4 million.

Altra Holdings (Nasdaq: AIMC) 16% HIGHER; reports Q1 EPS of $0.12, 7 cents better than the analyst estimate of $0.05. Revenue for the quarter was $124.5 million, versus the consensus of $114.61 million. The company continues to forecast 2009 sales in the range of $460 million to $500 million and recurring diluted EPS in the range of $0.25 to $0.45 for the full year. (FY revenue consensus is $488.25M and EPS consensus is $0.41)

Hologic (Nasdaq: HOLX) 15.6% LOWER; reports Q2 EPS of $0.29, ex-items, 2 cents better than the analyst estimate of $0.27. Revenue for the quarter was $402 million, versus the consensus of $405.10 million. Sees Q3 EPS of $0.25-$0.27, versus the Street estimate of $0.27 and revs of $390-$400 million, versus the consensus of $409 million. Sees FY09 EPS of $1.10-$1.15, versus the consensus of $1.12 and revs of $1.625-$165 billion, versus the Street estimate of $1.66 billion.

Myriad Genetics (Nasdaq: MYGN) 15.5% LOWER; reports Q3 EPS of $0.23, 1 cent lower than the analyst estimate of $0.24. Revenue for the quarter was $87.5 million, versus the consensus of $90.49 million.

Gasco Energy (Amex: GSX) 14% LOWER; reports Q1 EPS of $0.02, ex-items, 2 cents better than the analyst estimate of $0.00. Revenue for the quarter was $4.2 million, versus the consensus of $8.2 million.

National Interstate (Nasdaq: NATL) 10.4% HIGHER; reports Q1 EPS of $0.65, versus the analyst estimate of $0.41.

Array BioPharma Inc. (Nasdaq: ARRY) 10% LOWER; reports Q1 loss of $0.62, 3 cents worse than the analyst estimate of ($0.59). Revenue for the quarter was $6.04 million, versus the consensus of $7.05 million.

Corporate Executive Board Company (Nasdaq: EXBD) 9.6% LOWER; reports Q1 EPS of $0.40, 15 cents better than the analyst estimate of $0.25. Revenue for the quarter was $117.4 million, versus the consensus of $112.84 million. Based on the sales environment in the first quarter and the near-term extended purchase and renewal decision-making cycle anticipated in our target member base, CEB is reducing its 2009 guidance to a range for revenues of $410- $450 million and non-GAAP diluted earnings per share of $0.90 to $1.40. (consensus is $452.43M and 1.27, respectively) The Company is decreasing its quarterly dividend from $0.44 per share to $0.10 per share, which will preserve approximately $46 million cash for the Company on an annualized basis.

ATS Medical (Nasdaq: ATSI) 9.4% HIGHER; reports Q1 loss of $0.02, 1 cent better than the analyst estimate of ($0.03). Revenue for the quarter was $18.4 million, versus the consensus of $17.56 million. For the full year 2009 the Company reaffirmed its previous revenue guidance of $77 to $80 million representing a year-over-year growth rate of approximately 17 to 22%. (Consensus is $78.29M)

Herbalife Ltd. (NYSE: HLF) 8% HIGHER; reports Q1 EPS of $0.68 adjusted, 9 cents better than the analyst estimate of $0.59. Revenue for the quarter was $521.7 million, versus the consensus of $514 million.

Carrols Restaurant Group (Nasdaq: TAST) 7.8% HIGHER; reports Q1 EPS of $0.23, 1 cent better than the analyst estimate of $0.22. Revenue for the quarter was $201.3 million, versus the consensus of $201.12 million. Diluted earnings per share of $0.90 to $0.95, which includes the 53rd week of the fiscal year and which is estimated to positively impact earnings by approximately $0.07 per diluted share. This compares to the Company’s previous guidance of diluted earnings per share of $0.75 to $0.80, inclusive of the extra fiscal week. (Consensus is $0.93)

Innophos (Nasdaq: IPHS) 6.5% HIGHER; reports Q1 EPS of $1.39, versus the analyst estimate of $1.27. Revenue for the quarter was $190.8 million, versus the consensus of $179.77 million.

Chesapeake Energy Corporation (NYSE: CHK) 6% LOWER; reports Q1 adj-EPS of $0.46, 2 cents lower than the analyst estimate of $0.48. Revenue for the quarter was $2 billion, versus the consensus of $2.20 billion.

Powerwave Technologies (Nasdaq: PWAV) 4.5% HIGHER; reports Q1 loss of $0.02, 4 cents better than the analyst estimate of ($0.06). Revenue for the quarter was $149.7 million, versus the consensus of $161.76 million.

Immersion Corporation (Nasdaq: IMMR) 4.4% LOWER; reports Q1 loss of $0.27, 4 cents below the analyst estimate of ($0.23). Revenue for the quarter was $7 million, versus the consensus of $7.54 million.

D.R. Horton (NYSE: DHI) 4.2% LOWER; reports Q1 loss of $0.34, 4 cents lower than the analyst estimate of ($0.30). Revenue for the quarter was $775.3 million, versus the consensus of $817.49 million.

Holly Energy Partners, L.P. (NYSE: HEP) 3.7% LOWER; intends to offer, subject to market and other conditions, 2,000,000 common units representing limited partner interests in the Partnership in a public offering. In connection with the offering, the Partnership expects to grant the underwriters a 30-day option to purchase up to 300,000 additional common units.

McKesson Corporation (NYSE: MCK) 3% LOWER; reports Q4 EPS of $1.23 ex-items, 8 cents better than the analyst estimate of $1.15. Revenue for the quarter was $26.2 billion, versus the consensus of $27.30 billion. Sees FY10 EPS $3.90 to $4.05 versus consensus $4.09.

To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• Dividend
• After-Hours Movers

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?